Metabolic Gene Expression in Fetal and Failing Human Heart

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-12-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HC4901.100526PMID 11739307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling Pathways Responsible for Fetal Gene Induction in the Failing Human Heart: Evidence for Altered Thyroid Hormone Receptor Gene Expression

  2001cited by this paper
• Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.

  2001cited by this paper
• Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles.

  2001cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart.

  2001cited by this paper
• Differential Regulation of Carnitine Palmitoyltransferase-I Gene Isoforms (CPT-I α and CPT-Iβ ) in the Rat Heart

  2001cited by this paper
• Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply.

  2000cited by this paper
• Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure.

  2000cited by this paper
• The role of the cytoskeleton in heart failure.

  2000cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction.

  2000cited by this paper
• Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy

  1999cited by this paper
• Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms.

  1999cited by this paper
• Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy

  1998cited by this paper
• Differential regulation in the heart of mitochondrial carnitine palmitoyltransferase-I muscle and liver isoforms

  1998cited by this paper
• GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues.

  1998cited by this paper
• Myosin heavy chain gene expression in human heart failure.

  1997cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Mitochondrial Carnitine Palmitoyltransferase I Isoform Switching in the Developing Rat Heart (*)

  1995cited by this paper
• Differential localization of atrial natriuretic peptide and skeletal alpha-actin messenger RNAs in left ventricular myocytes of patients with dilated cardiomyopathy.

  1995cited by this paper
• Myocardial lipid turnover in dilated cardiomyopathy: A dual in vivo tracer approach

  1995cited by this paper
• Developmental, nutritional, and hormonal regulation of tissue-specific expression of the genes encoding various acyl-CoA dehydrogenases and alpha-subunit of electron transfer flavoprotein in rat.

  1993cited by this paper
• Tissue specific and developmental expression of rat long-and medium-chain acyl-CoA dehydrogenases.

  1993cited by this paper
• Developmental changes in energy substrate use by the heart.

  1992cited by this paper
• Human fetal heart development after mid-term: morphometry and ultrastructural study.

  1992cited by this paper
• Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue.

  1992cited by this paper
• Differential regulation of glucose transporter isoforms by thyroid hormone in rat heart.

  1992cited by this paper
• Atrial natriuretic factor: a ventricular hormone?

  1990cited by this paper
• Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

  1990cited by this paper
• Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy.

  1990cited by this paper
• Effects of moderate hypertension on cardiac function and metabolism in the rabbit.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Release and regulation of atrial natriuretic peptide (ANP).

  1987cited by this paper
• Mechanized techniques for the selective extraction of enzymes from plant epidermal glands.

  1987cited by this paper
• Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.

  1983cited by this paper
• Effects of dantrolene and D2O on K+-stimulated respiration of skeletal muscle.

  1982cited by this paper
• Ultrastructural and enzymatic development of fetal guinea pig heart.

  1982cited by this paper
• Myocardial Consumption of Oxygen and Carbohydrates in Newborn Sheep

  1981cited by this paper
• Myocardial enzyme activities in guinea pigs during development.

  1977cited by this paper
• Isozyme patterns in erythrocytes from human fetuses

  1977cited by this paper
• Development and adaptation of heart mitochondrial respiratory chain function in fetus and in newborn.

  1976cited by this paper
• Increased oxidative metabolism in the fetal and newborn lamb heart.

  1972cited by this paper

• Global deletion of potassium channel Kv1.5 causes biventricular heart failure

  2026cites this paper
• Fatty Acid Transport at the Heart of Metabolic Adaptation.

  2026cites this paper
• METTL7B-induced histone lactylation prevents heart failure by ameliorating cardiac remodelling.

  2025cites this paper
• Interferon gamma signaling drives cardiac metabolic rewiring

  2025cites this paper
• Human fetal circulating factors from pregnancies complicated by obesity upregulate genes associated with pathological hypertrophy in neonatal rat cardiomyocytes.

  2025cites this paper
• Embryonic transcripts in heart failure: Time for reprogrammed thinking?

  2025cites this paper
• Lipid exposure leads to metabolic dysfunction in fetal sheep cardiomyocytes

  2025cites this paper
• Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model

  2025cites this paper
• Reducing Granules Without Splicing Restoration Alleviates RBM20 Cardiomyopathy

  2025cites this paper
• Mitochondrial Dysfunction in Cardiac Surgery.

  2025cites this paper
• A ratiometric catalog of protein isoform shifts in the cardiac fetal gene program

  2025cites this paper
• Metabo-epigenetic circuits of heart failure: chromatin-modifying enzymes as determinants of metabolic plasticity

  2025cites this paper
• Increased CPT1a Expression Is a Critical Cardioprotective Response to Pathological Stress that Suppresses Gene Programs for Remodeling and Enables Rescue by Gene Transfer.

  2025cites this paper
• Predicting metabolic preferences through transcriptomics: a data-driven approach to align metabolic signatures with gene expression profiles

  2025cites this paper
• Enhancing Mitochondrial Maturation in iPSC-DerivedCardiomyocytes: Strategies for Metabolic Optimization

  2025cites this paper
• Transcriptional regulation in heart development, disease and regeneration: reassessing the fetal gene hypothesis

  2025influential citation
• Nonmuscle α-Actinin-4 Couples Sarcomere Function to Cardiac Remodeling

  2025cites this paper
• Mitochondrial DNA depletion syndrome and its cardiac complication

  2025cites this paper
• Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets

  2025cites this paper
• AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model

  2025cites this paper
• HUMAN FETAL CIRCULATING FACTORS FROM PREGNANCIES COMPLICATED BY MATERNAL OBESITY INDUCE HYPERTROPHY IN NEONATAL RAT CARDIOMYOCYTES

  2025cites this paper
• Role of circadian rhythms in heart failure: insights from myocardial energy metabolism

  2025cites this paper
• Empagliflozin’s cardioenergetic protective effects through PPARα pathway modulation in heart failure

  2025cites this paper
• Cardiac fibrogenesis: an immuno-metabolic perspective

  2024cites this paper
• Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors.

  2024cites this paper
• Increased CPT1a expression is a critical cardioprotective response to pathological stress that suppresses gene programs for remodeling and enables rescue by gene transfer

  2024cites this paper
• Human cardiac metabolism.

  2024cites this paper
• Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy

  2024cites this paper
• Cardiac wasting in patients with cancer

  2024cites this paper
• Molecular Pathways and Animal Models of Cardiomyopathies.

  2024cites this paper
• The Structure of the Cardiac Mitochondria Respirasome Is Adapted for the β-Oxidation of Fatty Acids

  2024cites this paper
• 25-Hydroxycholecalciferol Improves Cardiac Metabolic Adaption, Mitochondrial Biogenetics, and Redox Status to Ameliorate Pathological Remodeling and Functional Failure in Obese Chickens

  2024cites this paper
• Characterisation of infantile cardiomyopathy in Alström syndrome using ALMS1 knockout induced pluripotent stem cell derived cardiomyocyte model.

  2024cites this paper
• Metabolic Choreography of Energy Substrates During DCD Heart Perfusion

  2024cites this paper
• Towards Metabolomic-Based Precision Approaches for Classifying and Treating Heart Failure

  2024cites this paper
• Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy

  2024cites this paper
• Carrying both the heterozygous Myh6-R453C and Tnnt2-R92W mutations aggravate the hypertrophic cardiomyopathy phenotype in mice.

  2024cites this paper
• Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy

  2024cites this paper
• Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways

  2024cites this paper
• Activation of IP3R in atrial cardiomyocytes leads to generation of cytosolic cAMP

  2024cites this paper
• Maintenance of Cardiac Microenvironmental Homeostasis: A Joint Battle of Multiple Cells

  2024cites this paper
• Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation

  2024cites this paper
• Differential Regulation of Immune-Related Genes in the Developing Heart

  2024cites this paper
• A Ratiometric Catalog of Protein Isoform Shifts in the Cardiac Fetal Gene Program

  2024cites this paper
• Mechanism of heart failure after myocardial infarction

  2023cites this paper
• Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.

  2023cites this paper
• Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/− During Development

  2023cites this paper
• NAD+ controls circadian rhythmicity during cardiac aging

  2023cites this paper
• A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

  2023cites this paper
• Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy

  2023cites this paper
• Modeling Cardiomyocyte Signaling and Metabolism Predicts Genotype to Phenotype Mechanisms in Hypertrophic Cardiomyopathy

  2023cites this paper
• Metabolic adaptations in pressure overload hypertrophic heart

  2023cites this paper
• Functional Impact of Alternative Metabolic Substrates in Failing Human Cardiomyocytes

  2023cites this paper
• Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery disease

  2023cites this paper
• Cardiomyopathy in Asian Cohorts: Genetic and Epigenetic Insights

  2023cites this paper
• Effects of hypoxia in cardiac metabolic remodeling and heart failure.

  2023cites this paper
• Beneficial Effects of Halogenated Anesthetics in Cardiomyocytes: The Role of Mitochondria

  2023cites this paper
• Fetal metabolic adaptations to cardiovascular stress in twin-twin transfusion syndrome

  2023cites this paper
• The secretome as a biomarker and functional agent in heart failure

  2023cites this paper
• Hypoxic Stress-Dependent Regulation of Na,K-ATPase in Ischemic Heart Disease

  2023cites this paper
• Sustained Increases in Cardiomyocyte Protein O‐Linked β‐N‐Acetylglucosamine Levels Lead to Cardiac Hypertrophy and Reduced Mitochondrial Function Without Systolic Contractile Impairment

  2023cites this paper
• Analysis of Fatty Acid Metabolism in Fetal and Failing Hearts by Single-Cell RNA Sequencing Revealed SLC27A6 as a Critical Gene in Heart Maturation.

  2023cites this paper
• ELECTROSPUN NANOFIBERS IN TREATMENT OF MYOCARDIAL INFARCTION: A REVIEW

  2023cites this paper
• Cardiac maturation.

  2023cites this paper
• Non-Coding RNA-Mediated Gene Regulation in Cardiovascular Disorders: Current Insights and Future Directions

  2023cites this paper
• Myocardial Metabolism in Heart Failure

  2023cites this paper
• A role for misaligned gene expression of fetal gene program in the loss of female-specific cardiovascular protection in young obese and diabetic females

  2023cites this paper
• Current advances of Mitochondrial dysfunction and cardiovascular disease and promising therapeutic strategies.

  2023influential citation
• Iron Deficiency and Deranged Myocardial Energetics in Heart Failure

  2022cites this paper
• Mechanotransduction regulates inflammation responses of epicardial adipocytes in cardiovascular diseases

  2022cites this paper
• AIBP Regulates Metabolism of Ketone and Lipids but Not Mitochondrial Respiration

  2022cites this paper
• Prohibitin1 maintains mitochondrial quality in isoproterenol‐induced cardiac hypertrophy in H9C2 cells

  2022cites this paper
• Mass spectrometry-based metabolomics for clinical study: Recent progresses and applications

  2022cites this paper
• Quantitative analysis of kruppel-like factor 5-related messenger RNA transcripts in ischemic myocardium for discrimination of death causes

  2022cites this paper
• Deiodinases control local cellular and systemic thyroid hormone availability.

  2022cites this paper
• Metabolomic and Transcriptomic Signatures of Chemogenetic Heart Failure.

  2022cites this paper
• Integrated landscape of cardiac metabolism in end-stage human nonischemic dilated cardiomyopathy

  2022cites this paper
• Defining the Fetal Gene Program at Single-Cell Resolution in Pediatric Dilated Cardiomyopathy

  2022cites this paper
• Exercise training counteracts the cardiac metabolic remodelling induced by experimental pulmonary arterial hypertension.

  2022cites this paper
• Metabolic Regulation of Cardiac Regeneration

  2022cites this paper
• Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma

  2022cites this paper
• A remarkable adaptive paradigm of heart performance and protection emerges in response to marked cardiac-specific overexpression of ADCY8

  2022cites this paper
• Study on diverse pathological characteristics of heart failure in different stages based on proteomics

  2022cites this paper
• Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies

  2022cites this paper
• Cardiac metabolic remodelling in chronic kidney disease

  2022cites this paper
• Energy Metabolism on Mitochondrial Maturation and Its Effects on Cardiomyocyte Cell Fate

  2022cites this paper
• Moderate heart rate reduction promotes cardiac regeneration through stimulation of the metabolic pattern switch.

  2022cites this paper
• Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.

  2022cites this paper
• Diet-Induced Hypercholesterolemia Leads to Cardiac Dysfunction and Alterations in the Myocardial Proteome

  2022cites this paper
• Mitochondria in Pathological Cardiac Remodeling.

  2022cites this paper
• Cardio-omentopexy requires a cardioprotective innate immune response to promote myocardial angiogenesis in mice

  2022cites this paper
• In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms

  2022cites this paper
• Cellular Heterogeneity of the Heart

  2022cites this paper
• Traditional Chinese medicine enhances myocardial metabolism during heart failure.

  2021cites this paper
• Mitochondrial Dysfunction and Mitochondrial Therapies in Heart Failure.

  2021cites this paper
• Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

  2021cites this paper
• Glucagon-Like Peptide-1 and Psychiatric Disorder

  2021cites this paper
• Selenoprotein DIO2 Is a Regulator of Mitochondrial Function, Morphology and UPRmt in Human Cardiomyocytes

  2021cites this paper
• A Foot Soldier in Cardiac Metabolism: A Conversation With Heinrich Taegtmeyer, MD, DPhil.

  2021cites this paper
• Adaptation of the heart to Frataxin depletion: Evidence that integrated stress response can predominate over mTORC1 activation.

  2021cites this paper